Long-term Safety and Efficacy Profile of ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

203

Participants

Timeline

Start Date

December 3, 2021

Primary Completion Date

March 31, 2026

Study Completion Date

April 30, 2026

Conditions
Ulcerative Colitis
Interventions
DRUG

ABX464

All subjects will receive ABX464 given at 25 mg QD.

Trial Locations (46)

Unknown

Medizinische Universitaet Innsbruck, Innsbruck

Medical University of Vienna, Vienna

Antwerp University Hospital, Antwerp

UZ Leuven, Leuven

South Edmonton Gastroenterology, Edmonton

Fakultni nemocnice u sv. Anny v Brne, Brno

Nemocnice Slany, Slaný

Centre Hospitalier Universitaire Grenoble Alpes, Grenoble

Centre Hospitalier Universitaire De Montpellier, Montpellier

CHU Nantes - Hôtel Dieu, Nantes

Institut des MICI, Neuilly-sur-Seine

CHU Saint Etienne - Hôpital Nord, Saint-Etienne

Goethe University Frankfurt, Frankfurt

Studiengesellschaft BSF UG (haftungsbeschraenkt), Halle

Medizinische Hochschule Hannover, Hanover

DRC Gyogyszervizsgalo Kozpont Kft., Balatonfüred

Semmelweis University, Budapest

Vasutegeszseguegyi Nonprofit Koezhasznu Kft., Debrecen

Győr-Moson-Sopron Vármegyei Petz Aladár Egyetemi Oktató Kórház I. Belgyógyászat, Győr

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma

Humanitas Mirasole S.p.A., Rozzano

IRCCS Ospedale Sacro Cuore Don Calabria, Verona

Centrum Medyczne Plejady, Krakow

Niepubliczny Zaklad Opieki Zdrowotnej Neuromed M. i M. Nastaj sp. p, Lublin

Wojskowy Szpital Kliniczny w Lublinie, Lublin

Medicome Sp. z o. o., Oświęcim

Trialmed CRS, Piotrkow Trybunalski

Termedia Sp. z o.o (NSZOZ Termedica - Centrum Badan Klinicznych), Poznan

"Ośrodek Badań Klinicznych METABOLICA", Tarnów

Medical Network Sp. z o.o., Warsaw

Santa Sp. z o.o., Warsaw

Centrum Badan Klinicznych Piotr Napora Lekarze Spolka Partnerska, Wroclaw

Centrum Medyczne Oporow, Wroclaw

LexMedica, Wroclaw

Kliničko bolnički centar Zvezdara, Belgrade

"Opšta bolnica Đorđe Joanović Zrenjanin Odsek za gastroenterologiju", Zrenjanin

Cliniq s.r.o., Bratislava

GASTRO I, s.r.o., Prešov

Endomed s.r.o, Vranov nad Topľou

Splošna bolnišnica Celje, Celje

Univerzitetni klinični center Maribor, Maribor

Splosna Bolnisnica Murska Sobota, Murska Sobota

Centro Medico Teknon, Barcelona

"Communal non-commercial enterprise Cherkasy Regional Hospital of Cherkasy regional council", Cherkasy

"Communal non-commercial enterprise Khmelnytska Regional Hospital of Khmelnytskiy regional council", Khmelnytskyi

21-010

Samodzielny PZOZ w Lecznej, Łęczna

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Abivax S.A.

INDUSTRY

NCT05177835 - Long-term Safety and Efficacy Profile of ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis | Biotech Hunter | Biotech Hunter